Claire Pressiat

ORCID: 0000-0003-0728-2701
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Antibiotics Pharmacokinetics and Efficacy
  • Pregnancy and Medication Impact
  • Inflammasome and immune disorders
  • Pharmacological Effects and Toxicity Studies
  • HIV Research and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Antifungal resistance and susceptibility
  • Pharmaceutical studies and practices
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Cardiac Ischemia and Reperfusion
  • Intramuscular injections and effects
  • interferon and immune responses
  • Biomedical and Engineering Education
  • Autoimmune and Inflammatory Disorders
  • Lung Cancer Treatments and Mutations
  • Autoimmune and Inflammatory Disorders Research
  • Gout, Hyperuricemia, Uric Acid
  • Colorectal Cancer Treatments and Studies
  • Antimicrobial Resistance in Staphylococcus
  • Infectious Aortic and Vascular Conditions
  • Immunodeficiency and Autoimmune Disorders
  • Quality and Safety in Healthcare
  • Maternal Mental Health During Pregnancy and Postpartum

Assistance Publique – Hôpitaux de Paris
2015-2024

Hôpitaux Universitaires Henri-Mondor
2019-2024

Inserm
2022-2024

Institut Mondor de Recherche Biomédicale
2022-2024

Université Paris-Est Créteil
2020-2024

École Nationale Vétérinaire d'Alfort
2022-2024

Centre Hospitalier Universitaire Henri-Mondor
2019-2021

GTx (United States)
2021

Hôpital Albert-Chenevier
2019

Saint Louis University Hospital
2018

Abstract The paradigm type I interferonopathy Aicardi-Goutières syndrome (AGS) is most typically characterized by severe neurological involvement. AGS considered an immune-mediated disease, poorly responsive to conventional immunosuppression. Premised on a chronic enhancement of interferon signaling, JAK1/2 inhibition has been trialed in AGS, with clear improvements cutaneous and systemic disease manifestations. Contrastingly, treatment efficacy at the level system less conclusive. Here, we...

10.1007/s10875-023-01500-z article EN cc-by Journal of Clinical Immunology 2023-05-12

Background: A sensitive liquid chromatography coupled with tandem mass spectrometry (MS/MS) method for the analysis in a small volume of plasma 14 tyrosine kinase inhibitors currently used (imatinib, dasatinib, ibrutinib, ponatinib, trametinib, sunitinib, cobimetinib, dabrafenib, erlotinib, lapatinib, nilotinib, bosutinib, sorafenib, and vemurafenib) has been developed validated. This multianalyte MS/MS assay is interest anticancer drug combination therapy. Methods: After simple protein...

10.1097/ftd.0000000000000357 article EN Therapeutic Drug Monitoring 2016-11-18

AIMS Pregnant women can be exposed to numerous drugs during the gestational period. For obvious ethical reasons, in vivo studies of fetal exposure are limited. Information about transplacental transfer prior their administration pregnant would highly useful. In present study, a novel approach was developed quantitatively predict or administered mother quantitatively. Methods Transplacental parameters estimated from ex human placenta perfusion experiments were implemented...

10.1111/bcp.12815 article EN British Journal of Clinical Pharmacology 2015-10-31

A simple, rapid, and sensitive liquid chromatography coupled with tandem mass spectrometry method has been developed validated for the quantification of ruxolitinib, olaparib, vismodegib, pazopanib in human plasma.After a simple protein precipitation plasma samples, chromatographic separation was performed using an ultraperformance system positive ionization mode. The mobile phase consisted gradient elution 10-mmol/L formate ammonium buffer containing 0.1% (vol/vol) formic acid (phase A)...

10.1097/ftd.0000000000000497 article EN Therapeutic Drug Monitoring 2018-02-23

In Schnitzler syndrome, which is mostly diagnosed with a low and asymptomatic monoclonal peak, anakinra has always exhibited complete but only transient control of the auto-inflammatory signs, are induced by interleukin (IL)-1 auto-activation. We focused on treatment case syndrome moderate macroglobulinemia peak. Anakinra failed to improve severe inflammatory anaemia dysglobulinemia, rituximab-dexamethasone-cyclophosphamide chemotherapy alone allowed response. The correlation between...

10.1159/000368349 article EN Dermatology 2014-11-27

ABSTRACT The aims of this study were to describe the unbound and total lopinavir (LPV) pharmacokinetics in pregnant women order evaluate if a dosing adjustment is necessary during pregnancy. Lopinavir placental transfer described, several genetic covariates tested explain its variability. A 400 maternal, 79 cord blood, 48 amniotic fluid samples collected from 208 for LPV concentration determinations analysis. Among maternal concentrations, also used measure concentrations. Population models...

10.1128/aac.00863-15 article EN Antimicrobial Agents and Chemotherapy 2015-07-07

Adjusting drug therapy under veno-venous extracorporeal membrane oxygenation (VV ECMO) is challenging. Although impaired pharmacokinetics (PK) VV ECMO have been reported for sedative drugs and antibiotics, data about amiodarone are lacking. We evaluated the of both in vitro vivo.

10.3390/pharmaceutics14050974 article EN cc-by Pharmaceutics 2022-04-30

Aims This prospective study aimed to develop a population pharmacokinetics (PK) model of hydroxyurea (HU) in patients with sickle cell disease. can be used determine the impact glomerular filtration rate (GFR) on HU kinetics. Methods We included 30 patients. They underwent analyses plasma and urine. Six PK 2 periods without angiotensin‐converting enzyme inhibitor. was assayed validated high‐performance liquid chromatography‐UV method. Noncompartmental analysis conducted built Monolix....

10.1111/bcp.14653 article EN British Journal of Clinical Pharmacology 2020-11-21

Mitochondrial permeability transition pore (mPTP) opening is critical for mediating cell death during hepatic ischaemia-reperfusion injury (IRI). Blocking mPTP by inhibiting cyclophilin D (CypD) a promising pharmacological approach the treatment of IRI. Here, we show that diastereoisomers new class small-molecule inhibitors (SMCypIs) have properties make them attractive candidates development therapeutic agents against liver IRI.Derivatives parent SMCypI were synthesised and evaluated their...

10.1016/j.jhepr.2023.100876 article EN cc-by JHEP Reports 2023-08-16

The weaker diffusion of echinocandins in the peritoneal fluid (PF) could promote

10.1128/aac.01187-21 article EN Antimicrobial Agents and Chemotherapy 2021-10-18

A clinical study was conduct in HIV-infected children to evaluate the prophylactic doses of cotrimoxazole [sulfamethoxazole (SMX) and trimethoprim (TMP)] advised by WHO.Children received lopinavir-based antiretroviral therapy with prophylaxis (200 mg SMX/40 TMP once daily). nonlinear mixed effects modelling approach used analyse plasma concentrations. Factors that could impact pharmacokinetic profile were investigated. The model subsequently simulate individual exposure different...

10.1111/bcp.13397 article EN British Journal of Clinical Pharmacology 2017-08-11

Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) support leads to complex pharmacokinetic alterations, whereas adequate drug dosing is paramount for efficacy and absence of toxicity in critically ill patients. Amikacin a major antibiotic used nosocomial sepsis, especially these We aimed describe amikacin pharmacokinetics on V-A ECMO determine relevant variables improve its dosing. All patients requiring empirical antimicrobial therapy, including sepsis supported or not by ECMO,...

10.3390/pharmaceutics14020289 article EN cc-by Pharmaceutics 2022-01-26

Objective: This study aimed to analyze the outcomes and challenges associated with surgical redo procedures following aortic valve replacement for acute infective endocarditis. While transcatheter implantation is growing in terms of its utilization degenerative bioprostheses failure, valve-in-valve are limited Surgical interventions prosthesis endocarditis carry a significant risk, higher mortality morbidity, often requiring concomitant complex procedures. Methods: was retrospective,...

10.3390/jcm13247690 article EN Journal of Clinical Medicine 2024-12-17

The MONOD ANRS 12206 trial was designated to assess simplification of a successful lopinavir (LPV)-based antiretroviral treatment in HIV-infected children younger than 3 years age using efavirenz (EFV; 25 mg/kg body weight/day) preserve the class protease inhibitors for that group. In this substudy, EFV concentrations were measured check consistency an dose and compare it with 2016 FDA recommended dose. Fifty-two underwent blood sampling pharmacokinetic study at 6 months 12 after switching...

10.1128/aac.00297-17 article EN Antimicrobial Agents and Chemotherapy 2017-05-09

The OPTIPRIM-ANRS 147 trial compared intensive combination ART (darunavir/ritonavir, tenofovir disoproxil fumarate/emtricitabine, raltegravir and maraviroc) started early during primary HIV-1 infection with standard tritherapy darunavir/ritonavir, fumarate emtricitabine. From month 6 to 18, the percentage of viral load values <50 copies/mL was lower in pentatherapy arm than arm. Here we antiretroviral drug concentrations between two arms.Plasma samples were collected from 50 patients at...

10.1093/jac/dkx498 article EN Journal of Antimicrobial Chemotherapy 2017-12-19

The medical and university department of biology pathology at Henri Mondor hospital in Creteil has been engaged an NF EN ISO 15189 accreditation process since 2014. One the elements this concerns quality handling samples their transportation to laboratories, including implementation place requires fighting against pre-examination non-conformities, which are source many dysfunctions. group implemented several actions a targeted care service. Thanks these, rate non-conformities halved 18...

10.1684/abc.2020.1593 article EN Annales de biologie clinique 2020-12-01
Coming Soon ...